Osteopore Limited

ASX Code



Health Care Equipment & Services

Investor Centre





Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry. The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the Osteopore products provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone. Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use. Osteopore's proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton. Osteopore's core technology, the 3D printed biomimetic micro architecture which facilitates the bone healing process, provides multiple opportunities for growth through developing surgical implants and for pursuing regulatory approval for its products to initiate revenue opportunities. 3D printed biomimetic micro architecture is used in all of Osteopore's products.


Creating bone regeneration products for a global market
Be Careful Venturing Into The Wild West